Sexual health issues after lung transplantation: Importance of cervical screening

Journal of Heart and Lung Transplantation

Volumn 23, Issue 7, 2004, Pages 894-897

  Malouf, Monique A ^a   Hopkins, Peter M ^a   Singleton, Lisa ^a   Chhajed, Prashant N ^a   Plit, Marshall L ^a   Glanville, Allan R ^a  

^a ST VINCENT S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; MYCOPHENOLIC ACID; PREDNISOLONE; TACROLIMUS; THYMOCYTE ANTIBODY;

ADULT; AGED; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CYSTIC FIBROSIS; EISENMENGER COMPLEX; EMPHYSEMA; FEMALE; HEART TRANSPLANTATION; HEART VENTRICLE SEPTUM DEFECT; HUMAN; INCIDENCE; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PERFORMANCE; POPULATION SIZE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; SCREENING; SEXUAL BEHAVIOR; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX EPITHELIUM; VIRUS INFECTION; WART VIRUS;

ADULT; CERVICAL INTRAEPITHELIAL NEOPLASIA; CERVIX UTERI; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; IMMUNOSUPPRESSION; INCIDENCE; LUNG TRANSPLANTATION; MIDDLE AGED; NEW SOUTH WALES; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POSTOPERATIVE PERIOD; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 3242659719     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2003.07.018     Document Type: Article

References (22)

1. Durst M., Gissmann L., Ikenberg H., Zur Hausen H. A papillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions. Proc Natl Acad Sci U S A. 80:1983;3812-3815
2. Bosch F.X., Manos M.M., Munoz N., et al. Prevalence of human papillomavirus in cervical cancer a worldwide perspective. International Biological Study on Cervical Cancer. (IBSCC) Study Group J Natl Cancer Inst. 87:1995;796-802
3. Munoz N., Bosch F.X., Shah K.V., Meheus A. The Epidemiology of Human Papillomavirus and Cervical Cancer IARC. Scientific Publication No. 119. 1992;International Agency for Research on Cancer, Lyon
4. Sun X.W., Kuhn L., Ellerbrock T.V., Chiasson M.A., Bush T.J., Wright T.C. Jr. Human papillomavirus infection in women infected with the human immunodeficiency virus. N Engl J Med. 337:1997;1343-1349
5. Ogunbiyi O.A., Scholefield J.H., Raftery A.T., et al. Prevalence of anal human papillomavirus infection and intraepithelial neoplasia in renal allograft recipients. Br J Surg. 81:1994;365-367
6. Sasadeusz J., Kelly H., Szer J., Schwarer A.P., Mitchell H., Grigg A. Abnormal cervical cytology in bone marrow transplant recipients. Bone Marrow Transplant. 28:2001;393-397
7. Buehler J.W., Ward J.W. A new definition for AIDS surveillance. Ann Intern Med. 118:1993;390-392
8. The Bethesda System for reporting cervical/vaginal cytologic diagnoses: revised after the second National Cancer Institute Workshop, April 29-30, 1991. Acta Cytol 1993;37:115-24
9. Walton R.J. The task force on cervical cancer screening programs. Can Med Assoc J. 114:1976;981
10. Joste N.E., Rushing L., Granados R., et al. Bethesda classification of cervicovaginal smears reproducibility and viral correlates. Hum Pathol. 27:1996;581-585
11. Kivlahan C., Ingram E. Papanicolaou smears without endocervical cells. Are they inadequate? Acta Cytol. 30:1986;258-260
12. Richart R.M., Barron B.A. A follow-up study of patients with cervical dysplasia. Am J Obstet Gynecol. 105:1969;386-393
13. Thomas D.B., Ray R.M. Oral contraceptives and invasive adenocarcinomas and adenosquamous carcinomas of the uterine cervix. The World Health Organization Collaborative Study of Neoplasia and Steroid Contraceptives. Am J Epidemiol. 144:1996;281-289
14. Ursin G., Peters R.K., Henderson B.E., d'Ablaing G. III, Monroe K.R., Pike M.C. Oral contraceptive use and adenocarcinoma of cervix. Lancet. 344:1994;1390-1394
15. Meanwell C.A. The epidemiology and etiology of cervical cancer. Blackledge G.R.P., Jordan J.A., Shingleton H.M. Textbook of Gynaecologic Oncology. 1991;250 WB Saunders, Philadelphia
16. Schiffman M.H., Brinton L.A. The epidemiology of cervical carcinogenesis. Cancer. 76:1995;1888-1901
17. Brinton L.A., Reeves W.C., Brenes M.M., et al. Oral contraceptive use and risk of invasive cervical cancer. Int J Epidemiol. 19:1990;4-11
18. Holowaty P., Miller A.B., Rohan T., To T. Natural history of dysplasia of the uterine cervix. J Natl Cancer Inst. 91:1999;252-258
19. National Health, and Medical Research Council. Screening to Prevent Cervical Cancer. Guidelines for the Management of Women With Screen Detected Abnormalities. 1994;Australian Government Publishing Service, Canberra
20. Fait G., Daniel Y., Kupferminc M.J., Lessing J.B., Niv J., Bar-Am A. Does typing of human papillomavirus assist in the triage of women with repeated low-grade, cervical cytologic abnormalities? Gynecol Oncol. 70:1998;319-322
21. Sherman M.E., Schiffman M.H., Strickler H., Hildesheim A. Prospects for a prophylactic HPV vaccine rationale and future implications for cervical cancer screening. Diagn Cytopathol. 18:1998;5-9
22. Koutsky L.A., Ault K.A., Wheeler C.M., et al. A controlled trial of a human papillomavirus type 16 vaccine. N Engl J Med. 347:2002;1645-1651